Global Depression Drugs Market 2015-2019

1. Published June-2015 No. of Pages 107 (Single User License of the Report is Available at US $3000) Global Depression Drugs Market 2015-2019 Reach us at Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org Visit: http://www.sandlerresearch.org

2. The analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019. According to the report, WHO has described depression as one of the most disabling illnesses worldwide. In 2012, it was estimated that more than 18 million people suffered from depression in the US, affecting about 25% of women and 10% of men. According to the CDC, about one in every 10 individuals in the US suffers from depression. The prevalence rate of depression is very high because of factors such as genetic vulnerability, lack of proper diagnosis and treatment, and a high degree of association with other medical disorders such as diabetes, stroke, cardiovascular diseases, and psychiatric disorders. Global Depression Drugs Market 2015-2019 CAGR Forecast Purchase a Copy at http://www.sandlerresearch.org/purchase?rname=38098

3. This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the mechanism of action of the drugs used to treat depression, as mentioned below: • Tricyclic antidepressants • Serotonin-norepinephrine reuptake inhibitors • Selective serotonin reuptake inhibitors • Monoamine oxidase inhibitors • Others • Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Global Depression Drugs Market 2015-2019 Report Covers Inquire Further on the Report at http://www.sandlerresearch.org/inquire-before-buying?rname=38098

4. According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors. According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are more likely to be affected by depression than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating disorders in the US and affects about 14.80 million adults aged 18 years and above. Global Depression Drugs Market 2015-2019 • About Depression Drugs Read Full Report at http://www.sandlerresearch.org/global-depression-drugs-market-2015-2019.html

5. Market Driver Rise in patient population • Market Challenge Threat of expiry of patents • Market Trend Growing public awareness Global Depression Drugs Market 2015-2019 Market Key Components Discount on the Report at http://www.sandlerresearch.org/discount?rname=38098

6. Actavis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline and Pfizer Global Depression Drugs Market 2015-2019 Key Vendors Other Prominent Vendors Abbott Laboratories AddexTherapeutics Alkermes AstraZeneca AurobindoPharma AvanirPharmaceuticals Cerecor Chugai Pharmaceutical Dart NeuroScience Dr. Reddy’s Laboratories Edgemont Pharmaceuticals E-Therapeutics Evotec F. Hoffmann-La Roche Fabre Kramer GedeonRichter H. Lundbeck Intra-Cellular Therapies Janssen Pharmaceuticals Lupin LuyePharma MSI Methylation Sciences Naurex Neuralstem Novartis Order By Fax: http://www.sandlerresearch.org/order-by-fax?rname=38098

7. Global Depression Drugs Market 2015-2019 Key Regions Browse Other Reports on Pharmaceutical Market

8. What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Global Depression Drugs Market 2015-2019 Key Questions Answered in this Report Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org

9. About US: Sandlerresearch.org (http://www.sandlerresearch.org/ ) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. Mail US at: sales@sandlerresearch.org Phone: + 1 888 391 5441 Find US: